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Abstract
Background: Necrotizing fasciitis is a rare, life threatening soft tissue infection, primarily involving the fascia and
subcutaneous tissue. In a large cohort of patients presenting with Necrotizing fasciitis in the Netherlands we
analysed all available data to determine the causative pathogens and describe clinical management and outcome.
Methods: We conducted a retrospective, multicentre cohort study of patients with a necrotizing fasciitis between
January 2003 and December 2013 in an university medical hospital and three teaching hospitals in the Netherlands.
We only included patients who stayed at the Intensive Care Unit for at least one day.
Results: Fifty-eight patients were included. The mortality rate among those patients was 29.3 %. The central part
of the body was affected in 28 patients (48.3 %) and in 21 patients (36.2 %) one of the extremities. Most common
comorbidity was cardio vascular diseases in 39.7 %. Thirty-nine patients (67.2 %) were operated within 24 h after
presentation. We found a type 1 necrotizing fasciitis in 35 patients (60.3 %) and a type 2 in 23 patients (39.7 %).
Conclusions: Our study, which is the largest study in Europe, reaffirmed that Necrotizing fasciitis is a life threatening
disease with a high mortality. Early diagnosis and adequate treatment are necessary to improve the clinical outcome.
Clinical awareness off necrotizing fasciitis remains pivotal.
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Background
Necrotizing fasciitis (NF) is a part of the Necrotizing
Soft Tissue Infections. It’s a rare, life threatening soft tis-
sue infection, primarily involving the fascia and subcuta-
neous tissue. Although the symptoms were already
described in the fifth century BC by Hippocrates [1, 2],
even in modern medicine it still has a high mortality rate
ranging from 6 to 76 % [1, 3–6]. The term necrotizing
fasciitis was introduced by Wilson in 1952 [1, 7].
The rapidly progressive infection can affect any part of
the body. The portal of entry usually is a minor injury of
the affected site or a surgical wound. However, no de-
finitive cause can be found in 20–50 % [8–10].
Medical conditions associated with necrotizing fasci-
itis are diabetes mellitus (31–44 %), obesity (28 %),
smoking (27 %), alcoholabusus (17 %), cirrhosis (8–15 %),
malignancy (3 %), corticosteroid therapy (3 %) and chronic
renal failure (3 %) [11, 12].
The incidence of NF is low with 0.4 cases per 100.000
in the United Kingdom [13].
Clinical symptoms consist of local symptoms like ery-
thema, swelling, changes in skin colouring, intense
pain, bullae and sometimes subcutaneous emphysema
and general symptoms such as fever, nausea, vomiting
and malaise [2, 8, 11].
Necrotizing fasciitis can be classified in four clinical
forms, depending on the causative organisms [2]. In Type
1 at least one anaerobic species is isolated with one or
more facultative anaerobic streptococci (other than group
A) and members of the Enterobacteriaceae (e.g., E.coli, En-
terobacter, Klebsiella, Proteus) [14]. Type 2 is generally
monomicrobial and caused by hemolytic streptococcus
group A, sometimes with co-infection of Staphylococcus
aureus. Most articles show type 1 is more common, with a
relative incidence up to 75 % [8, 9]. Some studies also de-
scribe type 3, caused by the marine Vibrio spp. The portal
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of entry for this type 3 NF is a puncture wound caused by
fish or marine insects and is rarely observed in Europe
[11]. Type 4 describes fungal cases of candida NF, which
are very rare [2, 15].
The diagnosis of NF should be considered in patients
with clinical symptoms as mentioned above, but can be
very difficult. To clarify the diagnosis, Wong et all de-
scribed the “Laboratory Risk Indicator for Necrotizing
Fasciitis” (LRINEC) score, which is based on routinely per-
formed laboratory tests [6] (Table 1). They found a score
≥6 had a positive predictive value of 92 % and a negative
predictive value of 96 %. However, this test has not been
validated in larger, prospective studies. Therefore, surgical
exploration remains the gold standard to definitively es-
tablish the diagnosis of necrotizing fasciitis [8, 16]. Ag-
gressive surgical debridement (<24 h) is associated with a
lower mortality [17, 18].
Appropriate treatment of a patient with NF can only
be achieved through close cooperation between the sur-
geon, intensivist and microbiologist.
The aim of our study was to analyse all available data of
a large cohort of patients presenting with NF in four
teaching hospitals in the Netherlands. Also, we determined
the causative pathogens in our population, described clin-
ical management and clinical outcome in this Dutch co-
hort and compared that with previous other studies.
Methods
Study design
The study was designed as a retrospective cohort study.
Patients
All consecutive adult patients who were diagnosed with
NF were eligible for inclusion at the Radboud University
Medical Center Nijmegen (Radboudumc) (a 900 beds uni-
versity hospital), the Gelderse Vallei Hospital Ede (GVH)
(a 500 beds hospital), Rijnstate Hospital Arnhem (RH) (a
950 beds hospital) and Slingeland Hospital Doetinchem
(SH) (a 340 beds hospital) between January 2003 and
December 2013. These hospitals are located in the
Central-Eastern part of the Netherlands, belonging to
one surgical training region.
For inclusion, patients had to stay at the intensive care
unit for at least one day. Patients were found by hospital
data system, diagnostic codes and microbiological results.
Data collection
Diagnosis of necrotizing fasciitis was proven by histopath-
ologic examination of tissue samples or surgical findings
when no tissue sample was analyzed. This means the pres-
ence of an affected fascia, which was documented in the
procedure note as a necrotizing fasciitis, was diagnostic.
Vital parameters (e.g., temperature, blood pressure, heart
rate), clinical symptoms of the affected body part and la-
boratory results at presentation, as well as all demographic
data were collected from the patient charts. Results of
blood and wound cultures, the number of surgical inter-
ventions, operative findings, length of stay at the intensive
care unit (ICU), total duration of hospitalization and the
mortality rate were documented. For all patients the LRI-
NEC score was calculated from the laboratory findings.
We considered Type 2 FN as caused by a monoculture
of hemolytic streptococcus group A (Streptococcus pyo-
genes), or in rare cases caused by Staphylococcus aureus
or hemolytic streptococcus group C or G.
And in contrast Type 1 FN was seen as caused by dif-
ferent combinations of anaerobic bacteria, aerobic gram
negative rods from the Enterobacteriaceae group and
streptococci other than Streptococcus pyogenes.
Results
Initial assessment
A total of 58 patients were included (19 Radboudumc;
15 GVH, 16 RH, 8 SH). Thirty-four patients were male
(58.6 %) and 24 were female (41.4 %). The median age
was 62 years (range 21–81 years).
Localisation of the fasciitis was in the central part of
the body in 28 patients (48.3 %) and in one of the ex-
tremities in 21 patients (36.2 %). In 8 patients (13.8 %)
there was a combination of central part of the body with
one of the extremities. In one patient the head was the
affected.
The most common comorbidity was cardiovascular dis-
eases (39.7 %). Other co-morbidities included were obesity
Table 1 The Laboratory Risk Indicator for Necrotizing Fasciitis
(LRINEC score)
Score
C-reactive protein (mg/l) <150 0
≥150 4
Leucocyte count (109/l) <15 0
15–25 1
>25 2
Haemoglobine (mmol/l) >8.4 0
6.8–8.4 1
<6.8 2
Sodium (mmol/l) ≥135 0
<135 2
Creatinine (μmol/l) ≤141 0
>141 2
Glucose (mmol/l) ≤10 0
>10 1
Total 13
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(25.9 %), diabetes mellitus (24.1 %) and malignancy
(19.0 %). Thirteen patients (22.4 %) had no comorbidities.
Etiology of the necrotizing fasciitis was a minimal
trauma in 16 patients (27.6 %) (median 4 days, range 1–
30). Fourteen patients had undergone an operation a few
days before they developed necrotizing fasciitis (median
3.3 days, range 1–60). Seven of them had undergone a
sterile operation (e.g., inguinal hernia repair or lumpec-
tomie), the other seven patients a contaminated oper-
ation (e.g., appendicitis or bowel resection) (Table 2). In
28 patients (48.3 %) there was no portal of entry or no
known cause for the NF.
Nineteen patients (32.8 %) had a fever at time of presen-
tation with a body temperature of >38.5 °C. Signs and
symptoms at admission were swelling (54 cases, 93.1 %),
erythema (52 cases, 89.7 %), tachycardia (33 cases, 57.9 %)
and blisters (14 cases, 24.1 %). Other symptoms like crepi-
tation or loss of sensibility were rare. Figure 1a shows a
swelling and erythema matching a necrotizing fasciitis.
Forty-six patients had a LRINEC score ≥ 6 (79.3 %), 33
patients had a score ≥ 8 (56.9 %) and 8 patients had a
score ≥ 10 (13.8 %). The mean LRINEC score was 7.4.
Microbiology
All 58 patients had positive cultures. We found a type 1
necrotizing fasciitis in 35 patients (60.3 %) and a type 2
in 23 patients (39.7 %). In 9 out of 35 patients (25.7 %)
with a type 1 NF, we isolated a monoculture, mostly E.
coli. In the other 26 patients (74.3 %), a total of 61
(mixed) pathogens were isolated (Table 3).
Treatment and follow up
All patients underwent one or more operations. Thirty-
nine patients (67.2 %) were operated within 24 h and 16
patients (27.6 %) underwent their first operation after 24 h.
In 3 patients the exact time of operation was not clear.
Forty-nine patients (84.5 %) underwent radical necro-
tectomy. In 6 cases (10.3 %) an amputation was necessary.
In 3 patients the NF was so extensive, that because of poor
prognosis, radical necrotectomy was not conducted.
The mean number of debridement procedures of the
patients who survived was 2.8 (range 1–8). In 26 patients
(44.8 %) we used vacuum assisted closure therapy, which
in 12 patients was followed by definitive reconstruction by
split skin grafts (Fig. 1b-d). Other patients received split
skin grafts without VAC® (Vacuüm Assisted Closure) ther-
apy, primary wound closure or reconstruction by the plas-
tic surgeon.
The mortality was 17 out of 58 patients (29.3 %). The
median age of the patients who died was 64 years (range
38–72 years). The median age of the survivors was 59 years
(range 21–81 years). Nine patients died within 2 days be-
cause of multi organ failure or cessation of treatment due
to poor prognosis. Two patients died in the first week
after admission. Six patients died several weeks or months
(range 15–73 days) after admission because of a new sep-
tic period, cardiac failure or general weakness.
Table 2 Operations prior to necrotizing fasciitis
Sterile Number Contaminated Number
Inguinal hernia repair 2 Bowel resection 4
Renal transplantation 1 Hemorrhoidectomy 2
Laparoscopic cholecystectomy 1 Appendectomy 1
Adnex extirpation 1
Lumpectomie 1
Vasectomy 1
Total 7 7
Fig. 1 A 65 year old women with a history of diabetes mellitus,
renal insufficiency and corticosteroid use, presented on the
emergency room with fever, progressive pain, erythema and
swelling in her left leg (a). Surgical debridement showed typical
signs of necrotizing fasciitis. Two weeks after presentation and
10 days after VAC therapy, she has got a split skin graft (b).
Follow up after 3 months (c) and 5 months (d) showed a
well-healed wound
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From 38 patients histological examinations were taken.
In two cases an autopsy was performed. All patients
showed typical signs of NF.
The mean duration of hospitalization of the patients
who survived was 46 days (range 11–166). The mean
stay on the intensive care unit was 11 days (range 1–42).
Discussion
Necrotizing fasciitis is a part of the Necrotizing Soft Tis-
sue Infections (NSTI) and is a rare life threatening dis-
ease that still has a high mortality and morbidity. We
included 58 patients with necrotizing fasciitis in four dif-
ferent hospitals. To our knowledge, this study is the first
Dutch study and involves one of the largest European
cohorts. Previous large studies have been conducted in
Asia and Australia [5–7, 19, 20]. Because we exclusively
wanted to include patients with the fulminant form of
necrotizing fasciitis, patients with NF admitted for at
least one day in the intensive care unit, were included.
Patients with a subacute fasciitis [21] or a doubtful diag-
nosis were excluded from our study.
Many patients presented with classical symptoms like
erythema, swelling and tachycardia, had abnormal blood
results and had a clear minimal trauma or a surgical
wound as the portal of entry. Despite the classical presen-
tation, up to 30 % was not operated on within 24 h after
admission. This is consistent with the literature, which
shows even higher numbers of delay of surgical treatment
up to 40 % [7, 20]. Also, Goh et all describes 71.4 % mis-
diagnosis of NF as cellulitis or abscess in their systematic
review [12]. This illustrates the diagnostic dilemma that is
present in a large number of patients.
The LRINEC score can be a useful tool to help diagnose
NF [6]. In the initial study, a score of 6 or above was
shown to have a positive predictive value of 92 % and a
negative predictive value of 96 % [6]. However, no prog-
nostic studies for validating this score, and the cut-off
value of ≥6, are available [22]. Twenty-one percent of our
patients had a LRINEC score below 6. However, this was a
selected group in which the diagnostic process had already
been completed. The LRINEC score was used retrospect-
ively and therefore did not aid in the diagnosis. If we want
to use the LRINEC score in this way, an adequate valid-
ation is necessary.
The most common risk factor for NF in the literature is
diabetes mellitus [5, 7, 11, 12, 23, 24], however, there are
major differences between studies (Bucca at all 21 %,
Wong at all 70.8 %) [6, 25]. In our study only 24.1 % of the
patients had diabetes. The most common comorbidity we
found was cardiovascular diseases in almost 40 % of the
patients. Over 50 % of them had a serious cardiac event
like infarction or arrhythmia. The other patients only had
hypertension. The number of patients with no comorbidi-
ties (22.4 %) is comparable to other studies [5, 19].
Many of the larger studies on NF are published in
South East Asia or Australia. These countries live in
close relation to marine life. In addition to type 1 and
type 2 NF, type 3 was described regularly. We had no
patients in our study with NF type 3. Huang described
11.9 % wound cultures with Vibrio spp, it was the most
common pathogen leading to bacteraemia (29.5 %) in
their population [7]. This difference in pathogens may
also have influenced the course of the disease and out-
come of patients with NF. In our study we found 60.3 %
of patients with type 1 NF and 39.7 % with type 2 NF.
This is similar to other studies [3, 8, 9]. Studies with
higher numbers of type 2 NF describe up to 63.3 %
type 2. These studies used other criteria to distinguish
between type 1 and 2, classifying all monomicrobial
infections as type 2 [7, 24, 26].
The treatment of patients with NF is challenging and
consists of adequate surgical debridement, supportive
care by the intensivist and starting broad spectrum
Table 3 Cultures in necrotizing fasciitis type I, n = 35 patients
Micro organism Monoculture Present in
mixed culture
Total
Escherichia coli 6 13 19
Klebsiella pneumoniae 1 1
Proteus mirabilis 3 3
Citrobacter freundii 1 1
Enterobacter cloacae 2 2
Serratia marcescens 1 1
Pseudomonas aeruginosa 1 1 2
Acinetobacter baumannii 1 1
Stenotrophomonas
maltophilia
1 1
Aeromonas sobria 1 1
Bacillus species 1 1
Haemolytic streptococci, not
group A
3 3
Enterococcus species 4 4
Streptococcus pneumoniae 1 1
Viridans streptococci 3 3
S.milleri group 6 6
Clostridium perfringens 2 2
Anaerobe gram negative rods,
mainly B.fragilis
1 5 6
Anaerobic mixed culture 5 5
Mixed culture 7 7
Total cultures 9 (13 %) 61 (87 %) 70
(100 %)
Total patients 9 (26 %) 26 (74 %) 35
(100 %)
van Stigt et al. World Journal of Emergency Surgery  (2016) 11:21 Page 4 of 6
antimicrobials [25, 27]. The choice of antibiotics de-
pends on the suspected causative microorganism(s),
part of the body that is affected and clinical picture.
Antibiotic therapy can be narrowed down as culture re-
sults are known. The most important factor is early sur-
gical aggressive debridement, which is associated with a
lower mortality when performed within 24 h [17, 18].
Mortality in our study population was 29 %, which is
slightly higher than in other reports of patients with NF
[5, 7, 10, 19, 20, 24, 25, 28]. This can be explained by the
different inclusion criteria and possible different micro-
organism(s). Due to the inclusion criteria of at least
1 day ICU-stay we possibly included a more seriously ill
population compared to other reports.
Recent years have shown an increase in the use of the
vacuum assisted therapy [29]. We used the VAC® therapy
in nearly half of our patients with good results.
Our study was limited by the retrospective character.
Another limitation is, because of the rarity of NF, pa-
tients of four different hospitals are included. Different
routines in the hospitals, although they belong to the
same training regions, and the relative long period of in-
clusion can explain some missing data.
Conclusions
We present the first Dutch and the largest European
study of patients with necrotizing fasciitis. Our study
reaffirmed that NF is a life threatening disease with a
high mortality. Early diagnosis and adequate treatment
are necessary to improve the clinical outcome. Clinical
awareness of necrotizing fasciitis remains pivotal.
Our recommendations for further research are a pro-
spective study to validate the LRINEC score and to explore
the correlation between the score and clinical outcome.
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